青光眼治疗药的全球市场(2023年):2022年～2028年的分析

本报告提供全球青光眼治疗药市场相关调查，青光眼治疗药市场现状分析，今后5年的市场效能预测。还有开发平台趋势，及加入此市场的主要企业的企业简介等资讯。

目录

• 青光眼种类与风险因素
• 青光眼的诊断和治疗
• 含眼科医生和验光师的青光眼照护提供者的世界性见解
• 全球青光眼的盛行率相关现状及5年预测
• 市场上青光眼治疗药与其作用机制
• 学名药和品牌药的比较和对市场的影响
• 青光眼医药品的开发平台
• 製造、销售青光眼治疗药的企业的简介

The "2023 Glaucoma Pharmaceuticals Market Report" features new regional sales forecasts, market share analysis of generics and branded drugs by drug class in the United States, new analysis of pipeline products, and a summary of ongoing clinical trials. Also included is an updated analysis of the global and regional prevalence of glaucoma and the latest breakdown of diagnosis and treatment paradigms.

SAMPLE VIEW

The report also features new survey data from the United States and Europe, including ophthalmologists' preferences for sustained drug delivery.

This report provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. The global market is analyzed based on Market Scope's eight regional/economic categories (the US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World), and also uses these categories in global forecasts for disease prevalence. In addition, the report explores data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment.

Coverage includes:

• Types of glaucoma and risk factors.

• Diagnosis and treatment of the disease.

• A global view of glaucoma care providers, including ophthalmologists and optometrists.

• Current estimates and five-year forecasts for disease prevalence worldwide.

• Glaucoma medications in the marketplace and their mechanisms of action.

• Discussion of generic versus branded drugs and their market impact.

• The development pipeline for glaucoma pharmaceuticals.

• Profiles of companies making and marketing glaucoma medications.

Author Profile:

Peter Downs

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.

Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm's monthly industry newsletter.